| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 4277067 | Urology Practice | 2014 | 8 Pages | 
Abstract
												The traditional view that stage Ta bladder cancer is invariably synonymous with low risk disease requires reevaluation. Modern management of stage Ta bladder cancer depends on initial risk stratification that allows for subsequent management based on a number of evidence-based guidelines. Given the usual long clinical course of stage Ta bladder cancer, such an approach ensures not only safe but also economical care of this group of patients.
											Keywords
												nonMIBCCISICUDNCCNIVTUBCUTUCMIBCTURBTAUANMIBCCtuEAUAmerican Urological AssociationEuropean Association of UrologyRiskPractice guidelinetransurethral bladder tumor resectionUpper Tract Urothelial CancerUrothelial bladder cancerMuscle invasive bladder cancerNational Comprehensive Cancer Network®Intravesical chemotherapyEvidence-based practiceUrinary bladderPapillaryCarcinoma in situCarcinoma
												Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Urology
												
											Authors
												Hugh Mostafid, Roger Kirby, John M. Fitzpatrick, Richard T. Bryan, 
											